Lisa Ricciardi
President and Chief Executive Officer
Replay available
Cognition Therapeutics, Inc. (NASDAQ: CGTX) Q2 2024 earnings conference call, held 2024-08-08. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Chief Financial Officer
Chief Medical Officer
Analyst, Canada Teach Channel
Analyst, HC Waylight
Analyst, MIANC
Analyst, Target
Watch the replay and follow the connected company analysis, news, and investor updates for Cognition Therapeutics, Inc..
WEBVTT 00:00:00.009 -- 00:00:03.412 Hello, and thank you for standing by. At this time, I would like to welcome you to the 00:00:03.412 -- 00:00:07.675 Cognition Therapeutics second quarter 2024 earnings call. 00:00:07.675 -- 00:00:10.897 All lines have been placed on mute to prevent any background noise. 00:00:10.897 -- 00:00:13.560 After the speaker's remarks, there will be a question and answer session. 00:00:13.560 -- 00:00:17.423 If you would like to ask a question during this time, simply press star followed by the 00:00:17.423 -- 00:00:21.205 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:21.205 -- 00:00:26.309 star one again. I would now like to turn the conference over to Tom Johnson. 00:00:26.309 -- 00:00:28.910 Please go ahead. 00:00:29.258 -- 00:00:32.039 Thank you, operator, and good morning, everyone. 00:00:32.039 -- 00:00:36.721 Welcome to the Cognition Therapeutics second quarter 2024 results conference call. 00:00:36.721 -- 00:00:41.463 With me today are Lisa Ricciardi, President and Chief Executive Officer, John Doyle, 00:00:41.463 -- 00:00:46.664 Chief Financial Officer, and Tony Coggiano, Chief Medical Officer. 00:00:46.664 -- 00:00:49.926 This morning, the company issued a press release detailing its financial results for 00:00:49.926 -- 00:00:53.827 the second quarter and first half of the 2024 fiscal year. 00:00:53.827 -- 00:00:57.308 We encourage everyone to read this morning's press release, as well as Cognition's quarterly 00:00:57.308 -- 00:01:02.483 report on Form 10-Q, annual report on Form 10-K, and periodic reports on Form 00:01:02.483 -- 00:01:06.765 8-K, which are now filed with the SEC and available on our website. 00:01:06.765 -- 00:01:10.127 In addition, this conference call is being w...